Monotherapy versus polytherapy of enoxaparin and hydroxychloroquine for the treatment of COVID-19: A randomized controlled clinical trial.

Amira S A Said Raghda R S Hussein Doaa Mahmoud Khalil Alzhraa M Fahmy Ahmed H A Hassanein Lamiaa N Abdelaty

Published in: Pharmacy practice (2022)

These findings suggest that Enoxaparin was safe, effective, and well tolerated and has a role in decreasing the progression of the disease and its complications while HCQ did not discover any evidence of extra therapeutic benefits.

Keyphrases

venous thromboembolism
coronavirus disease
combination therapy
sars cov
risk factors
randomized controlled trial
clinical trial
open label
smoking cessation
replacement therapy
respiratory syndrome coronavirus
study protocol